{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T21:01:10Z","timestamp":1764277270755,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00125-024-06264-8","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T10:01:54Z","timestamp":1725703314000},"page":"2598-2599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-8193","authenticated-orcid":false,"given":"Sigurd","family":"Lenzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"6264_CR1","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00125-024-06106-7","volume":"67","author":"A Coomans de Brach\u00e8ne","year":"2024","unstructured":"Coomans de Brach\u00e8ne A, Alvelos MI, Szymczak F et al (2024) Interferons are key cytokines acting on pancreatic islets in type 1 diabetes. Diabetologia 67:908\u2013927. https:\/\/doi.org\/10.1007\/s00125-024-06106-7","journal-title":"Diabetologia"},{"key":"6264_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2011.04.002","volume":"55","author":"S Kacheva","year":"2011","unstructured":"Kacheva S, Lenzen S, Gurgul-Convey E (2011) Differential effects of proinflammatory cytokines on cell death and ER stress in insulin-secreting INS1E cells and the involvement of nitric oxide. Cytokine 55:195\u2013201. https:\/\/doi.org\/10.1016\/j.cyto.2011.04.002","journal-title":"Cytokine"},{"key":"6264_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00125-013-3125-4","volume":"57","author":"A J\u00f6rns","year":"2014","unstructured":"J\u00f6rns A, Arndt T, Meyer zuVilsendorf A et al (2014) Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes. Diabetologia 57:512\u2013521. https:\/\/doi.org\/10.1007\/s00125-013-3125-4","journal-title":"Diabetologia"},{"key":"6264_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2337\/db19-0865","volume":"69","author":"A J\u00f6rns","year":"2020","unstructured":"J\u00f6rns A, Wedekind D, J\u00e4hne J, Lenzen S (2020) Pancreas pathology of latent autoimmune diabetes in adults (LADA) in patients and in a LADA rat model compared with type 1 diabetes. Diabetes 69:624\u2013633. https:\/\/doi.org\/10.2337\/db19-0865","journal-title":"Diabetes"},{"key":"6264_CR5","first-page":"2151","volume":"389","author":"KC Herold","year":"2023","unstructured":"Herold KC, Gitelman SE, Gottlieb PA, Knecht LA, Raymond R, Ramos EL (2023) Teplizumab: a disease-modifying therapy for type 1 diabetes that preserves beta-cell function. Diabetes Care 389:2151\u20132161","journal-title":"Diabetes Care"},{"key":"6264_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00109-020-01941-8","volume":"98","author":"A J\u00f6rns","year":"2020","unstructured":"J\u00f6rns A, Arndt T, Yamada S et al (2020) Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat. J Mol Med (Berl) 98:1125\u20131137. https:\/\/doi.org\/10.1007\/s00109-020-01941-8","journal-title":"J Mol Med (Berl)"},{"key":"6264_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00109-014-1137-2","volume":"92","author":"A J\u00f6rns","year":"2014","unstructured":"J\u00f6rns A, Akin M, Arndt T et al (2014) Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by beta cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes. J Mol Med (Berl) 92:743\u2013755. https:\/\/doi.org\/10.1007\/s00109-014-1137-2","journal-title":"J Mol Med (Berl)"},{"key":"6264_CR8","doi-asserted-by":"publisher","unstructured":"Lenzen S (2017) Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes. Diabetes Metab Res Rev 33. https:\/\/doi.org\/10.1002\/dmrr.2915","DOI":"10.1002\/dmrr.2915"},{"key":"6264_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2337\/db07-0520","volume":"57","author":"S Weksler-Zangen","year":"2008","unstructured":"Weksler-Zangen S, Raz I, Lenzen S et al (2008) Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat. Diabetes 57:279\u2013287. https:\/\/doi.org\/10.2337\/db07-0520","journal-title":"Diabetes"},{"key":"6264_CR10","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.2337\/db14-1018","volume":"64","author":"G Aharon-Hananel","year":"2015","unstructured":"Aharon-Hananel G, J\u00f6rns A, Lenzen S, Raz I, Weksler-Zangen S (2015) Antidiabetic effect of interleukin-1beta antibody therapy through beta-cell protection in the Cohen diabetes-sensitive rat. Diabetes 64:1780\u20131785. https:\/\/doi.org\/10.2337\/db14-1018","journal-title":"Diabetes"},{"key":"6264_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/08916939408995694","volume":"19","author":"DL Eizirik","year":"1994","unstructured":"Eizirik DL, Sandler S, Welsh N, Bendtzen K, Hellerstr\u00f6m C (1994) Nicotinamide decreases nitric-oxide production and partially protects human pancreatic-islets against the suppressive effects of combinations of cytokines. Autoimmunity 19:193\u2013198. https:\/\/doi.org\/10.3109\/08916939408995694","journal-title":"Autoimmunity"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06264-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06264-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:30:59Z","timestamp":1730107859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06264-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6264"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06264-8","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"type":"print","value":"0012-186X"},{"type":"electronic","value":"1432-0428"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u2019s relationships and activities"}},{"value":"The author was the sole contributor to this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}